รศ.ดร.ภญ.เอื้อมเดือน ประวาฬ

Publication

Scopus Author Profile

International Publication

• Pocasap P, Kongpetch S, Prawan A, Kaimuangpak K, Senggunprai L. Identification of Prognostic Factors in Esophageal Cancer Using Machine Learning: A Retrospective Study Based on the SEER Database. Journal of Clinical Medicine. 2026;15(8).
• Buranrat B, Sa-Ngiamwibool P, Prawan A, Kongpetch S, Pocasap P, Senggunprai L. Repurposing Rosiglitazone Induces Apoptosis Accompanied by Impaired Antioxidant Defense in Cholangiocarcinoma Cells: Findings from Proteomic and Functional Analyses. Pharmaceuticals. 2026;19(1).
• Pocasap P, Kaimuangpak K, Phukmee K, Prawan A, Kongpetch S, Senggunprai L. Unveiling the Anticancer Potential and Molecular Mechanisms of Fangchinoline Against Cholangiocarcinoma Using FTIR Microspectroscopy, In Vitro and In Silico Approaches. Integr Cancer Ther 2025; 24: 15347354251396513.
• Sa-Ngiamwibool P, Yoshinari K, Shizu R, Kongpetch S, Prawan A, Senggunprai L. Expression and Prognostic Implication of the Nuclear Receptors Farnesoid X Receptor and Pregnane X Receptor in Human Cholangiocarcinoma. Cancer Diagn Progn 2025; 5: 529-541.
• Jaidee R, Pocasap P, Jusakul A, Senggunprai L, Prawan A, Hong JH, Heng HL, Kukongviriyapan V, Teh BT, Kongpetch S. Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway. Biomedicine and Pharmacotherapy 2025 Jun 18; 189: 118273.
• Jaidee R, Jusakul A, Pocasap P, Kukongviriyapan V, Senggunprai L, Prawan A, Loilome W, Titapun A, Jareanrat A, Thanasukarn V, Khuntikeo N, Namwat N, Chamgramol Y, Thanee M, Wichian P, Hong JH, Guan P, Heng HL, Pairojkul C, Teh BT, Kongpetch S. Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. Sci Rep 2025 Mar 13; 15: 8621; Published online.
• Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V. Fisetin-induced cell death, apoptosis, and antimigratory effects in cholangiocarcinoma cells. Journal of Applied Pharmaceutical Science. 2025 Jan 5; 15(2):96-105.
• Pocasap P, Prawan A, Kongpetch S, Senggunprai L. Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma. Heliyon. 2024 June; 10: e32352.
• Mahaamnad N, Pocasap P, Kukongviriyapan V, Senggunprai L, Prawan A, Kongpetch S. Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells. Heliyon. 2024 May; 10: e31112.
• Oeurn K, Jusakul A, Jaidee R, Kukongviriyapan V, Senggunprai L, Prawan A, Kongpetch S. FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells. In Vivo. 2023 Jul-Aug;37(4):1628-1637.
• Arthan S, Yenjai C, Pornchoo C, Prawan A. Chemical constituents from the branches of Millettia brandisiana and their biological activities. Phytochemistry Letters. 2023 Feb :53;222-225.
• Sombatsri A, Sribuhom T, Pornchoo C, Prawan A, Yenjai C. Five new quinoline alkaloids from Sauropus hirsutus Beille and their cytotoxicity. Nat Prod Res. 2023 Feb;37(3):361-368.
• Malikrong P, Prawan A,Kongpetch S, Senggunprai L. Momordin ic triggers mitochondria-mediated apoptosis of cholangiocarcinoma cells and enhances the efficacy of conventional chemotherapeutic drugs. Farmacia. 2023 Feb;71(3):518–525.
• Butsri S, Kukongviriyapan V, Senggunprai L, Kongpetch S, Prawan A. 13-cis-retinoic acid inhibits the self-renewal, migration, invasion and adhesion of cholangiocarcinoma cells. Int J Mol Med 2023; 51. Published online 2023 Jan 21.
• Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V. Piperine Induces Cell Death, Apoptosis and Inhibits Migration in Cholangiocarcinoma Cells. Indian Journal of Pharmaceutical Education and Research. 2023 Jan-Mar; 57(1):161-166.
• Kaewmeesri P, Pocasap P, Kukongviriyapan V, Prawan A, Kongpetch S, Senggunprai L. Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein. Integr Cancer Ther 2022 Sep 27; 21: 15347354221124861.
• Senggunprai L, Kukongviriyapan V, Prawan A, Kongpetch S. Epidermal growth factor receptor as a potential target of momordin Ic to promote apoptosis of cholangiocarcinoma cells. J Pharm Pharmacol . 2022 Jul 15;74(7):996-1005.
• Butsri S, Kukongviriyapan V, Senggunprai L, Kongpetch S, Prawan A. All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. Oncol Lett. 2022 Jun;23(6):179.
• Jaidee R, Kukongviriyapan V, Senggunprai L, Prawan A, Jusakul A, Laphanuwat P, Kongpetch S. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. Life Sci. 2022 May 1; 296: 120427.
• Sribuhom T, Posri P, Khankeaw W, Pornchoo C, Prawan A, Tontapha S, Amornkitbamrung V, Yenjai C . A rare isoflavone-quinone and a new flavanone from the roots of Dalbergia stipulacea Roxb. Nat Prod Res 2022 Mar 17: 1-9.
• Arthan S, Pornchoo C, Prawan A, Tontapha S, Amornkitbamrung V, Yenjai C. Brandisianones F and G from Millettia brandisiana Kurz and their cytotoxicity. Nat Prod Res. 2022 Mar;36(5):1236-1244.
• Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V. Effects of Simvastatin in Combination with Anticancer Drugs on Proliferation and Migration in Cholangiocarcinoma Cells. Indian J Pharm Sci 2022 Jan 17;84(1):72-79.
• Laphanuwat P, Kongpetch S, Senggunprai L, Prawan A, Kukongviriyapan V. Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-kappaB Signaling Pathways. Asian Pac J Cancer Prev. 2022 Jan 1; 23: 115-123.